Antimicrobial and Anticancer Scaffolds in Medicinal Chemistry
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 30 November 2026 | Viewed by 1795
Editor
Interests: medicinal chemistry; organic synthesis; heterocycles; anticancer activity; antimicrobial activity; SAR
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Modern medicinal chemistry plays a key role in the design and synthesis of compounds with antibacterial and anticancer activity. These systems are often based on heterocyclic structures, transition metal complexes, and natural compounds and their analogues. In the field of anticancer therapy, particular attention is paid to compounds targeting specific signaling pathways in cancer cells, such as tyrosine kinase inhibitors and apoptotic protein modulators. In turn, to combat bacterial resistance, new classes of antibiotics, antimicrobial peptides, and drug delivery systems, such as nanocarriers, are being developed. The integration of computational chemistry, molecular biology, and materials technology enables the synthesis of new compounds and the creation of more selective and effective therapies. A review of current trends indicates the growing importance of targeted therapies and personalized medicine in the treatment of infections and cancer. We invite submissions of original articles, reviews, analyses, studies, and reports under this topic.
Prof. Dr. Monika Pitucha
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial
- anticancer
- synthesis
- complex
- organic compounds
- heterocyclic compounds
- SAR
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
